Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04572906 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
A Phase 2 study of Peripheral Nerve Injuries, sponsored by Neuraptive Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 51
- Enrollment target
- 10
- Study locations
NCT04572906 is a Phase 2 study of Peripheral Nerve Injuries that has completed, run by Neuraptive Therapeutics. The registered enrollment target is 51 participants, below the 456-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (89% lower). The trial reports 10 study locations across 8 states.
The verdict
NCT04572906, a Phase 2 study of Peripheral Nerve Injuries, has completed, sponsored by Neuraptive Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 51 participants
- Enrollment target
- 10
- Study locations
Study Summary
NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 16 and 80 years of age.
Conditions Studied
Interventions
- COMBINATION_PRODUCT NTX-001
Study Locations (10)
Florida
- UF Health - University of FL - Gainesville - Gainesville
- Orlando Health - Orlando
Maryland
- Curtis National Hand Center - Baltimore
- Johns Hopkins Bayview Medical Center - Baltimore
Illinois
- University of Chicago - Chicago
Indiana
- Indiana Hand to Shoulder Center - Indianapolis
Missouri
- Washington University - St Louis
Ohio
- The Ohio State University Wexner Medical Center Hand and Upper Extremity Center - Columbus
Virginia
- Virginia Commonwealth University - Richmond
Washington
- Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2024-06-27 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04572906
The ClinicalTrials.gov registry entry for NCT04572906 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 456-participant average among 8 other Peripheral Nerve Injuries trials with a reported enrollment target (89% lower). The listed sponsor is Neuraptive Therapeutics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Nerve Injuries appearing as the primary indexed condition, and to 1 intervention - of which NTX-001 is the first listed.
NCT04572906 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Florida, Maryland, Illinois.
Frequently Asked Questions
What is clinical trial NCT04572906 about?
NCT04572906 is a clinical study titled "Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries". NTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 16 and 80 years of age.
What is the current status of trial NCT04572906?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2020-09-25. Estimated completion is 2024-06-27.
What conditions does trial NCT04572906 study?
This clinical trial studies the following conditions: Peripheral Nerve Injuries.
What interventions are being tested in trial NCT04572906?
The interventions under investigation include: NTX-001 (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04572906?
This trial is sponsored by Neuraptive Therapeutics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04572906 being conducted?
This trial has 10 study locations across Florida, Illinois, Indiana, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Nerve Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)
RECRUITING · Phase 2
-
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
RECRUITING · Phase 2
-
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
RECRUITING · NA
-
Promoting Healing of Injured Nerves With Electrical Stimulation Therapy
RECRUITING · NA
-
Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)
RECRUITING · NA
-
A Comparison of NeuroSpan Bridge, NeuraGen Nerve Guide, and Nerve Autograft for Peripheral Nerve Repair
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.